Board Meeting

LYKA LABS LTD.

NSE : LYKALABSBSE : 500259ISIN CODE : INE933A01014Industry : Pharmaceuticals & DrugsHouse : Private
BSE128.50-0.75 (-0.58 %)
PREV CLOSE ( ) 129.25
OPEN PRICE ( ) 123.50
BID PRICE (QTY) 127.90 (141)
OFFER PRICE (QTY) 128.35 (2)
VOLUME 9485
TODAY'S LOW / HIGH ( )123.50 129.00
52 WK LOW / HIGH ( )89 143.5
NSE127.70-1.1 (-0.85 %)
PREV CLOSE( ) 128.80
OPEN PRICE ( ) 128.35
BID PRICE (QTY) 127.35 (49)
OFFER PRICE (QTY) 127.70 (2)
VOLUME 51306
TODAY'S LOW / HIGH( ) 125.00 129.40
52 WK LOW / HIGH ( )88.5 144.3

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.